ArticlePharmaceutics2026

Model-Based Design of Sustained-Release Formulations of Anti-TNF-α Monoclonal Antibodies for Intravitreal Administration.

Javier Reig-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.